IP Library › Granted Patent US 8,927,725
Granted Patent B2
US 8,927,725 · App. 13/310,242 · Granted Jan 6, 2015

Thio compounds

Inventors: Nigel H. Greig (Phoenix, MD); Weiming Luo (Lutherville, MD); David Tweedie (Baltimore, MD); Harold W. Holloway (Middle River, MD); Qian-Sheng Yu (Lutherville, MD); Edward J. Goetzl (San Francisco, CA)
Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,927,725
App. No.
13/310,242
Granted
Jan 6, 2015
Kind
B2
Abstract

A compound, or a pharmaceutically acceptable salt or ester thereof, having a structure of: wherein A, B and D are each oxygen or sulfur, provided that least one of A, B and D is sulfur; and R 1 -R 8 are each independently hydrogen, hydroxyl, acyl, substituted acyl, acyloxy, substituted acyloxy, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, aryl, substituted aryl, amino, substituted amino, halogen, heterocycloalkyl, substituted heterocycloalkyl, heteroaryl, substituted heteroaryl, or a thio-containing group.

Claims (11)

1. A compound, or a pharmaceutically acceptable salt thereof, having a structure of:

wherein A, B, D and E are each oxygen or sulfur, and R 2 -R 4 and R 6 -R 8 are each independently hydrogen, hydroxyl, acyl, substituted acyl, acyloxy, substituted acyloxy, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, alkoxy, substituted alkoxy, aryl, substituted aryl, amino, substituted amino, halogen, heterocycloalkyl, substituted heterocycloalkyl, heteroaryl, substituted heteroaryl, or a thio-containing group, provided that

A and B are sulfur, and D and E are oxygen, or

A and D are sulfur, and B and E are oxygen, or

B and E are sulfur, and A and D are oxygen, or

D and E are sulfur, and A and B are oxygen.

2. The compound of claim 1 , wherein each of R 2 -R 4 and R 6 -R 8 is hydrogen.

3. The compound of claim 1 , wherein the compound is:

or a pharmaceutically acceptable salt thereof.

4. A pharmaceutical composition comprising the compound of claim 1 and at least one pharmaceutically acceptable additive.

5. A compound or pharmaceutically acceptable salt thereof, having a structure of:

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2012
From: GOETZL, EDWARD J.
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 028090/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2012
From: GREIG, NIGEL; LUO, WEIMING; TWEEDIE, DAVID; HOLLOWAY, HAROLD W.; YU, QIAN-SHENG
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 027726/0940 →
Continuity (1)
Related Publication 20130143922A1 · Jun 6, 2013